John M. Evans - Apr 28, 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
CEO, Director
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Apr 28, 2022
Transactions value $
-$1,761,863
Form type
4
Date filed
5/2/2022, 06:51 PM
Previous filing
Apr 4, 2022
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $88.4K +12.2K +1.12% $7.22 1.1M Apr 28, 2022 Direct
transaction BEAM Common Stock Options Exercise $48.6K +47.2K +4.29% $1.03* 1.15M Apr 28, 2022 Direct
transaction BEAM Common Stock Sale -$143K -3.9K -0.34% $36.59 1.14M Apr 28, 2022 Direct F1, F2
transaction BEAM Common Stock Sale -$512K -13.7K -1.19% $37.48 1.13M Apr 28, 2022 Direct F1, F3
transaction BEAM Common Stock Sale -$262K -6.84K -0.6% $38.32 1.12M Apr 28, 2022 Direct F1, F4
transaction BEAM Common Stock Sale -$178K -4.5K -0.4% $39.49 1.12M Apr 28, 2022 Direct F1, F5
transaction BEAM Common Stock Sale -$44.8K -1.1K -0.1% $40.73 1.12M Apr 28, 2022 Direct F1, F6
transaction BEAM Common Stock Sale -$239K -6.45K -3.96% $36.98 157K Apr 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F7
transaction BEAM Common Stock Sale -$293K -7.75K -4.95% $37.84 149K Apr 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F8
transaction BEAM Common Stock Sale -$120K -3.1K -2.08% $38.75 146K Apr 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F9
transaction BEAM Common Stock Sale -$93.3K -2.35K -1.61% $39.73 143K Apr 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F10
transaction BEAM Common Stock Sale -$14.6K -357 -0.25% $40.88 143K Apr 28, 2022 By John M. Evans, III 2018 Irrevocable Trust F1, F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -12.2K -5.49% $0.00 211K Apr 28, 2022 Common Stock 12.2K $7.22 Direct F12
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -47.2K -16.6% $0.00 237K Apr 28, 2022 Common Stock 47.2K $1.03 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.36 to $36.97, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.06 to $37.86, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.09 to $38.67, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $39.21 to $39.88, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.08 to $40.80, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.36 to $37.34, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.38 to $38.37, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.405 to $39.261, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $39.51 to $40.32, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.70 to $40.96, inclusive.
F12 The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested.
F13 The option vests as to 25% on the first anniversary of the of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested.